Jan 28, 2021 Remdesivir is the only antiviral drug approved for use in the U.S. against COVID-19. Photo courtesy of Gilead. More effective antiviral treatments could be on the way after research from The University of Texas at Austin sheds … Read more →

by Marissa Shapiro Jan. 27, 2021, 9:00 AM For the second time, cancer researchers at Vanderbilt have discovered a protein that—when genetically manipulated to impede it from interacting with a gene responsible for cancer genesis—effectively melts tumors in days.  The article, “MYC … Read more →

PHILADELPHIA, January 18, 2021 – According to the Centers for Disease Control, nearly three million people will acquire an antibiotic-resistant infection each year in the United States. Doctors are currently overprescribing antibiotics for feverish individuals during the pandemic, despite widespread … Read more →

GALVESTON, Texas –A collaborative team from The University of Texas Medical Branch at Galveston and Pfizer has shown that the common mutation N501Y from the newly emerged SRAS-CoV-2 strains does not compromise Pfizer’s COVID-19 vaccine. This is the first study to investigate if the … Read more →

SAN ANTONIO, Texas, USA – In a new paper, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) report brain chemistry that may contribute to why drinkers have difficulty paying attention while under … Read more →

The identification of this epigenetic process highlights potential drug treatment strategies for early-stage disease treatment. New findings suggest that late-onset Alzheimer’s Disease is driven by epigenetic changes—how and when certain genes are turned on and off—in the brain. Results were … Read more →

GALVESTON, Texas — Researchers from The University of Texas Medical Branch at Galveston have discovered SARS-CoV-2 proteins that suppress the body’s immune response, thereby enabling infection and transmission of the disease. The findings, recently published in the major research journal, … Read more →

Study provides research community with critical small animal model necessary for researchers developing therapies and vaccines SAN ANTONIO, TEXAS (July 23, 2020) Texas Biomedical Research Institute (Texas Biomed) scientists have added another tool to the COVID-19 toolbelt, validating a new … Read more →

This research was supported in part by the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation Click here for the full article https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.119.315185